Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
mBIOTA Elemental is a prescription-grade medical food (elemental diet) developed by mBIOTA Labs for the dietary management of gastrointestinal dysfunctions, including Small Intestinal Bacterial Overgrowth (SIBO), Intestinal Methanogen Overgrowth (IMO), Irritable Bowel Syndrome (IBS), and Inflammatory Bowel Disease (IBD). The product is a nutritional formula composed of nutrients in their most elemental, predigested forms—such as free amino acids, simple carbohydrates, and easily absorbed fats—along with essential vitamins and minerals. These components are rapidly absorbed in the upper gastrointestinal tract, which allows the distal gut to rest, reduces inflammation, and effectively starves invasive bacteria by depriving them of fermentable substrates. Developed in collaboration with leading gastroenterologists from Cedars-Sinai, the formula incorporates proprietary Amino Taste Modification Technology to improve palatability and has demonstrated high clinical efficacy and patient compliance in SIBO eradication trials.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on mBIOTA Elemental.